High Blood Cholesterol and High Blood Pressure: State of Knowledge Today and Implications for Prevention and Control of Epidemic Adult Cardiovascular Disease
This presentation aims to review the key data sets on the role of elevated serum cholesterol and elevated blood pressure in the production of mass premature coronary heart disease (CHD). Its purpose is to set down the information needed by the health professions and the general public to act effectively in the growing effort to control the contemporary CHD epidemic in the industrialized countries and to prevent its emergence in the developing countries. To aid in accomplishing this objective, a most useful document is the just published report of the World Health Organization Expert Committee on the Prevention of Coronary Heart Disease1This document summarizes current knowledge on these matters and on that basis presents an effective strategy for the health services and the general public for the effort to control this epidemic. (For an extensive review of the research literature in this field — i.e., the scientific basis of the preventive effort — see also the recently published Volume 2 of the Report of the Working Group on Arteriosclerosis of the U.S. National Heart, Lung, and Blood Institute2.
KeywordsHigh Blood Pressure Serum Cholesterol Serum Cholesterol Level High Blood Cholesterol Multiple Risk Factor Intervention Trial
Unable to display preview. Download preview PDF.
- 1.WHO Expert Committee on the Prevention of Coronary Heart Disease. Prevention of Coronary Heart Disease — Report of a WHO Expert Committee, World Health Organization, Geneva, Switzerland, Technical Report Series 678 (1982).Google Scholar
- 2.Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute, Report of the Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute, Vol.2, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No. 81–2035, Bethesda, MD, September 1981.Google Scholar
- 3.Inter-Society Commission for Heart Disease Resources. Atherosclerosis Study Group and Epidemiology Study Group. Primary Prevention of the Atherosclerotic Diseases, Circulation, 42:A55-A95 (1970). Revised April 1972.Google Scholar
- 5.WHO International Collaborative Group, WHO Regional Office for Europe, Myocardial Infarction Community Registers, Regional Office for Europe, World Health Organization, Copenhagen, Denmark (1977).Google Scholar
- 6.E. H. Ackerknecht, “Rudolf Virchow — Doctor, Statesman, Anthropologist,” Madison, WI, University of Wisconsin Press (1953).Google Scholar
- 7.A. Keys, ed., “Seven Countries — A Multivariate Analysis of Death and Coronary Heart Disease,” Cambridge, MA, Harvard University Press (1980).Google Scholar
- 9.J. Stamler, Improved life styles: Their potential for the primary prevention of atherosclerosis and hypertension in childhood; the fat-modified diet: its nature, effectiveness, and safety; can an effective fat-modified diet be safely recommended after weaning for infants and children in general? “Childhood Prevention of Atherosclerosis and Hypertension,” Edited by R. M. Lauer and R. B. Shekelle, New York, Raven Press, pp 3–36, 387–403 and 407–410 (1980).Google Scholar
- 15.N. Anitschkow, Experimental arteriosclerosis in animals, “Arteriosclerosis,” Edited by E. V. Cowdry, New York, Macmillan, pp 271–322 (1933).Google Scholar
- 17.T. B. Clarkson, M. G. Bond, B. C. Bullock, and C.A. Marzetta, A study of atherosclerosis regression in macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl, Exper.Molecular Path., 34:345–368 (1981).CrossRefGoogle Scholar
- 18.S. Dayton, M. L. Pearce, S. Hashimoto, W. J. Dixon, and U. Tomiyasu, A controlled clinical trial of a diet high in unsaturated fat — In preventing complications of atherosclerosis, Circulation, 39,40 (Suppl.2): 1–63 (1969).Google Scholar
- 23.J. Stamler, Hypertension: aspects of risk, J. C. Hunt, T. Cooper, E. D. Frohlich, R. W. Gifford Jr., N. M. Kaplan, J. H. Laragh, H. M. Maxwell, and C. G. Strong, eds., Hypertension Update: Mechanisms, Epidemiology, Evaluation, Management, Health Learning Systems, Inc., Bloomfield, N.J. pp.23–37 (1979).Google Scholar